HD-OPM Archive
Topics › Supplements & vitamins

Midlife vitamin D linked to later tau burden in Framingham participants

Louis Nervegna · Aug 01, 2026 · ♥ 20 reactions · 2 comments · original Facebook post
Supplements & vitaminsBrain health & dementia
AI summary & key facts

Researchers analyzed vitamin D in nearly 800 Framingham adults without dementia (mean age 39) and tau-PET scans about 16 years later. Louis notes a 20-year RCT is unlikely, so cohorts are the best option, though they cannot prove causation.

Dementia takes decades to develop.

Most randomized trials on vitamin D lasted only a few years.

So it is extremely unlikely that we would ever see a randomized trial that tests whether taking a vitamin D supplement for 20 years might lower risk for dementia and Alzheimer’s.

When it comes to the long term, the best we can do is look at high-quality prospective cohort studies such as the famous Framingham Heart Study. Prospective observational studies like the the Framingham Heart Study suffer from major problems such as confounding and reverse causality. They can only prove associations. Nevertheless, the Framingham study has been instrumental in understanding long-term risk factors for CVD. Now it is being used in a similar fashion to understand long-term risk factors for dementia and Alzheimer’s.

There is now evidence from randomized trials (such as VITAL) that vitamin D can lower risk for autoimmune conditions: ↪ VITAL: vitamin D 2000 IU for over 2 years cut autoimmune disease risk about 40%. This is especially true for multiple sclerosis: ↪ JAMA RCT: high-dose vitamin D reduced disease activity in early multiple sclerosis. The pathogenesis of Alzheimer’s and other forms of dementia might have an autoimmune component that vitamin D can causally address. (Emphasis on “might”.)

Link to journal paper:

Paper · Neurology Open Access · 2026Association of Circulating Vitamin D in Midlife With Increased Tau-PET Burden in Dementia-Free Adultsneurology.org

Links to press coverage of the study:

News-MedicalCould vitamin D in midlife protect your brain from early Alzheimer’s?Higher serum vitamin D in midlife is associated with reduced tau burden in the brain, highlighting its potential role in early dementia risk assessment.news-medical.net Fisher Center for Alzheimer's Research FoundationLow Vitamin D Levels Tied to Alzheimer’s Brain ChangesMen and women with low vitamin D levels in their 30s and 40s were at increased risk of having brain changes typical of Alzheimer’s disease later in life, accoalzinfo.org BrainHealth.comVitamin D in midlife linked to brain health later in lifeNew research suggests vitamin D may support brain health and may be linked to dementia-related brain changes later in life.brainhealth.com MDSpire NewsMidlife Vitamin D Linked to Lower TauHigher vitamin D levels in early midlife were tied to lower tau burden on later brain imaging, while no association was seen with amyloid.news.mdspire.com

#vitamindHD #framinghamHD #dementiaHD #alzheimersHD #tauHD #amyloidHD

Research cited

Research suggests that maintaining healthy levels of vitamin D during midlife may help reduce the accumulation of toxic tau proteins in the brain later in life, a key biomarker associated with Alzheimer’s disease.

In a study examining participants from the long-running Framingham Heart Study, scientists analyzed vitamin D levels in blood samples from nearly eight hundred adults who were free of dementia at an average age of thirty-nine.

Approximately sixteen years later, a substantial subset of these individuals underwent brain positron emission tomography scans to detect deposits of tau and amyloid beta proteins.

While no association emerged between midlife vitamin D status and amyloid beta, those with higher vitamin D concentrations showed significantly lower levels of tau tangles in the brain overall and in regions typically affected early in Alzheimer’s progression.

This finding marks one of the first investigations into the relationship between vitamin D in younger adults and later neuroimaging markers of preclinical dementia.

Previous work had primarily linked low vitamin D in people over seventy to elevated dementia risk, yet the current results indicate that the protective window may open earlier.

Researchers note that adequate vitamin D could support future brain health by potentially mitigating tau pathology, though the observational nature of the data means causation remains unproven.

Clinical trials would be needed to test whether supplementation in cognitively healthy middle-aged adults can meaningfully alter disease trajectories, especially given that higher or prolonged dosing might expand opportunities for intervention before irreversible damage occurs.

Source: Neurology Open Access, 2026.

No photo description available.
← newer: Most statin muscle pain is a nocebo effect, per the SAMSON tolder: Targeting senescent-cell inflammation (senomorphics) may bea →